Key result
Valvular heart disease peaks over age 75 in developed nations while rheumatic heart disease burdens developing regions.
Why the study?
The epidemiology and natural history of valvular heart disease have changed, with rheumatic heart disease declining in industrial nations and VHD becoming more prevalent with advancing age.
Population
Patients with valvular heart disease
Design
Review
Authors
Loading...
Highlights differing VHD burdens by region and age; leaves open targeted global prevention and screening strategies.
Valvular heart disease epidemiology varies globally, with rheumatic disease burdening developing nations and age-related VHD prevalent in developed nations.
Prendergast et al. (2010) studied this question. Valvular heart disease is a disease of advancing age in developed nations, particularly prevalent over age 75, while rheumatic heart disease remains a major burden in the developing world.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: